Filing Details
- Accession Number:
- 0000711377-21-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 21:19:08
- Reporting Period:
- 2021-03-31
- Accepted Time:
- 2021-04-01 21:19:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651434 | Edward John Adent | 822 7Th Street, Suite 740 Greeley CO 80631 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-31 | 25,826 | $62.70 | 45,906 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-31 | 14,638 | $63.90 | 60,544 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-31 | 40,464 | $87.99 | 20,080 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-03-31 | 25,826 | $0.00 | 25,826 | $62.70 |
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-03-31 | 14,638 | $0.00 | 14,638 | $63.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 257,514 | 2023-12-01 | No | 4 | M | Direct | |
| 242,876 | 2024-11-11 | No | 4 | M | Direct |
Footnotes
- Options were granted 11/1/2018, have rive year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
- Options were granted 10/11/2019, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
Billionaire Hedge Funds
